89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,009,851 | +12.9% | 1,619,809 | +38.5% | 0.01% | +25.0% |
Q2 2023 | $22,157,401 | -33.2% | 1,169,256 | -46.3% | 0.00% | -42.9% |
Q1 2023 | $33,188,531 | +156.0% | 2,179,155 | +114.0% | 0.01% | +133.3% |
Q4 2022 | $12,961,839 | +79.1% | 1,018,212 | -18.5% | 0.00% | +200.0% |
Q3 2022 | $7,236,000 | +105.2% | 1,249,822 | +14.1% | 0.00% | 0.0% |
Q2 2022 | $3,526,000 | +120.2% | 1,095,204 | +158.0% | 0.00% | – |
Q1 2022 | $1,601,000 | -54.7% | 424,519 | +57.0% | 0.00% | -100.0% |
Q4 2021 | $3,534,000 | -37.8% | 270,404 | -6.7% | 0.00% | 0.0% |
Q3 2021 | $5,678,000 | -37.9% | 289,854 | -40.7% | 0.00% | -50.0% |
Q2 2021 | $9,140,000 | -25.4% | 488,765 | -5.5% | 0.00% | -33.3% |
Q1 2021 | $12,253,000 | +2.6% | 517,467 | +5.6% | 0.00% | 0.0% |
Q4 2020 | $11,940,000 | +4833.9% | 489,953 | +5093.5% | 0.00% | – |
Q3 2020 | $242,000 | – | 9,434 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 11,416,948 | $173,880,118 | 3.94% |
Orchard Capital Management, LLC | 551,879 | $8,405,117 | 2.81% |
Cormorant Asset Management, LP | 2,800,000 | $42,644 | 2.81% |
SILVERARC CAPITAL MANAGEMENT, LLC | 438,215 | $6,674,014 | 2.76% |
Boxer Capital, LLC | 2,100,000 | $31,983 | 1.57% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,210,536 | $33,666,463 | 1.42% |
Resolute Capital Asset Partners LLC | 125,000 | $1,904 | 1.39% |
Velan Capital Investment Management LP | 98,500 | $1,500,155 | 1.28% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $3,046,000 | 1.26% |
Deep Track Capital, LP | 1,800,000 | $27,414,000 | 1.13% |